AG
CNCE

Aperio Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Aperio Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,601
Closed -$43K – 2877
2019
Q2 		$43K Buy
+3,601
New +$43K ﹤0.01% 2564